Novo Nordisk has released blockbuster bodyweight-loss drug Wegovy in Germany, its initial significant European market, hoping Germans pays countless euros away from pocket for just a drug that public health and fitness insurance ideas are thus far barred from covering.Although the terms “pharmacy” and “drugstore” may very well be applied in